IP Library Patent Application 12033419
Patent Application
App. No. 12/033,419

METHOD FOR INCREASING SEROTONIN LEVELS IN A PERSON BY ADMINISTRATION OF A COMPOSITION INCORPORATING (-)HYDROXYCITRIC ACID, AND RELATED COMPOSITIONS THEREOF

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/033,419
Abstract

A method for increasing serotonin levels in a person includes identifying a person having a deficient serotonin level and administering to the person a composition incorporating hydroxycitric acid, preferably in the form of an extract of Garcinia cambogia , in an amount sufficient to increase the person's serotonin levels. The method also can incorporate administering chromium, preferably in the form of oxygen-coordinated, niacin-bound chromium, and gymnemic acid, preferably in the form of an extract of Gymnema sylvestre, to synergistically work to further increase serotonin levels in the person.

Claims (19)

1 . A method for increasing serotonin levels in a person, comprising:

identifying a person having or at risk for having deficient serotonin levels; and

administering to the person a composition comprising an amount of (−)-hydroxycitric acid effective to increase serotonin levels in the person.

2 . A method as defined in claim 1 , wherein the step of administering comprises administering an amount of (−)-hydroxycitric acid effective to increase serotonin levels in the person sufficient to suppress the appetite of the person.

3 . A method as defined in claim 1 , wherein the step of administering comprises administering an amount of (−)-hydroxycitric acid effective to increase serotonin levels sufficient to alleviate mood disorders in the person.

4 . A method as defined in claim 3 , wherein the mood disorders include depression, anxiety, affective disorders, premenstrual dysphoria, insomnia, sleep-wake disturbances, binge eating, bulimia, and obsessive-compulsive disorders.

5 . A method as defined in claim 1 , wherein the step of administering comprises administering an amount of (−)-hydroxycitric acid effective to increase serotonin levels in the person sufficient to increase energy expenditure by the person.

6 . A method as defined in claim 1 , wherein the step of administering comprises administering an amount of (−)-hydroxycitric acid effective to increase serotonin levels in the person sufficient to promote decrease of body weight of the person.

7 . A method as defined in claim 1 , wherein the step of administering comprises administering a composition comprising an extract of Garcinia cambogia.

8 . A method as defined in claim 1 , wherein the step of administering comprises administering between about 2,700 and about 2,800 mg of (−)-hydroxycitric acid per day.

9 . A method as defined in claim 1 , wherein the step of administering comprises administering the composition in three approximately equal increments per day.

10 . A method as defined in claim 1 , wherein the step of administering comprises administering the composition between about 45 and about 60 minutes prior to consumption of a meal by the person.

11 . A method as defined in claim 1 , wherein the step of administering comprises administering a composition comprising an amount of chromium sufficient, in combination with the amount of (−)-hydroxycitric acid, to increase serotonin levels in the person.

12 . A method as defined in claim 11 , wherein the step of administering comprises administering a composition comprising niacin-bound chromium.

13 . A method as defined in claim 12 , wherein the step of administering comprises administering a composition comprising oxygen-coordinated, niacin-bound chromium.

14 . A method as defined in claim 11 , wherein the step of administering comprises administering about 400 mcg of chromium per day.

15 . The method of claim 1 , wherein the step of administering comprises administering a composition comprising an amount of gymnemic acid sufficient, in combination with the amount of (−)-hydroxycitric acid, to increase serotonin levels in the person.

16 . A method as defined in claim 15 , wherein the step of administering comprises administering a composition comprising an extract of Gymnema sylvestre.

17 . A method as defined in claim 15 , wherein the step of administering comprises administering about 100 mg of gymnemic acid per day.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Oct 5, 2016
From: MADISON CAPITAL FUNDING LLC
To: INTERHEALTH NUTRACEUTICALS INCORPORATED
Reel/Frame 040234/0538 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Sep 12, 2016
From: MADISON CAPITAL FUNDING LLC, AS ADMINISTRATIVE AGENT
To: INTERHEALTH NUTRACEUTICALS INCORPORATED
Reel/Frame 040068/0687 →
SECURITY AGREEMENT Recorded Dec 2, 2013
From: INTERHEALTH NUTRACEUTICALS INCORPORATED
To: MADISON CAPITAL FUNDING LLC (AS ADMINISTRATIVE AGENT)
Reel/Frame 031748/0036 →